Diphtheria
📧 Sign up to get email alerts when something new happens for Diphtheria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-26Clinical Trial Update: Immunogenicity and Safety of Adacel Polio Vaccine [Phase 3]
Phase 3 trial results summarize the immunogenicity and safety of Adacel Polio Vaccine; the study is completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. [Phase 3]
Phase 3 safety-focused trial comparing the DTaP-IPV-Hep B-PRP~T vaccine to Tritanrix-HepB/Hib and OPV when given at 2, 4, and 6 months.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older [Phase 4]
This Phase 4 trial evaluated the safety and immunogenicity of the ADACEL vaccine in adults 65 years and older, with results posted in 2012.
-
EMA withdrawal · 2012-08-16EMA Withdrawn: Hexavac (purified diphtheria toxoid;purified tetanus toxoid;purified pertussis toxoid;purified pertussis filamentous haemagglutinin;hepatitis B surface antigen;Inactivated Type 1 Poliovirus (Mahoney);Inactivated Type 3 Poliovirus (Saukett);Haemophilus influenzae type b polysaccharide) — Sanofi Pasteur MSD, SNC
The EMA has withdrawn Hexavac, a hexavalent combination vaccine, from the market. The decision was taken in 2012 and concerns multiple indic…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim in South African Infants [Phase 3]
A Phase 3 clinical trial evaluating the immunogenicity and safety of the Pentaxim vaccine in South African infants has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. [Phase 3]
A Phase 3 study comparing PENTAXIM with TETRAXIM when co-administered with ACTHIB in South Korean infants has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Pentaxim given as three-dose primary vaccination with an 18-month booster.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines [Phase 4]
Phase 4 clinical trial assessing immunogenicity and safety of PENTAXIM vaccine in the Philippines for diphtheria, tetanus, poliomyelitis, pe…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Pentaxim™ in an Indian Population [Phase 3]
Phase 3 trial evaluated immunogenicity and safety of Pentaxim in an Indian population. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV [Phase 3]
Phase 3 trial comparing the immunogenicity and safety of Tetraxim versus local DTP + IPV has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Sanofi Pasteur Pentaxim combined vaccine in infants in Thailand; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine [Phase 3]
Phase 3 trial evaluating safety, immunogenicity, and lot-to-lot comparability of the DTaP vaccine DAPTACEL when administered with other reco…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants [Phase 3]
This Phase 3 trial compares ACTACEL (DTaP-PRP-T) with separate DTaP and Act-HIB vaccines in healthy infants and has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine
A clinical trial update reports antibody persistence in healthy children after primary and booster vaccination with DTaP-IPV-Hep B-PRP-T com…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Pentavalent DTaP-Hep B-IPV [Phase 2]
Phase 2 trial of the pentavalent DTaP-Hep B-IPV vaccine has completed, evaluating protection against diphtheria, hepatitis B, poliomyelitis,…
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age [Phase 4]
Phase 4 study assessing immunogenicity and safety of a TETRAXIM booster given to children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Immunology of Non-specific Effects of Vaccine [Phase 4]
Phase 4 clinical trial evaluating non-specific immunological effects of vaccines has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® [Phase 2]
A Phase 2 trial evaluated concomitant administration of Menactra with a fifth dose of DAPTACEL in children aged 4 to 6 years. The study has …
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine [Phase 4]
Phase 4 post-marketing evaluation of adverse reactions following receipt of the recommended adolescent pertussis vaccine; sponsor is Sanofi …
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: A Study to Assess the Safety of Adacel® Vaccine [Phase 3]
Phase 3 safety study of Adacel vaccine completed; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td [Phase 4]
Phase 4 trial evaluating Canadian-manufactured tetanus and diphtheria toxoids adsorbed vaccine versus U.S.-manufactured Td; results posted i…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years [Phase 3]
Phase 3 trial updating immunogenicity and safety of Kinrix+ (MMR) with and without Varicella in healthy children 4-6 years; completed with r…
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults [Phase 3]
A Phase 3 booster study of a combined Diphtheria-tetanus-acellular Pertussis vaccine in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine [Phase 3]
Phase 3 trial update of reduced-antigen-content acellular pertussis vaccine and diphtheria-tetanus-acellular pertussis vaccine. The study ha…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 study comparing safety and immunogenicity of the Tdap vaccine to the DTaP vaccine in children aged 4 to 6 years, with results post…